Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble.
Liu, T.Y., Liu, J.J., Aditham, A.J., Nogales, E., Doudna, J.A.(2019) Nat Commun 10: 3001-3001
- PubMed: 31278272 
- DOI: 10.1038/s41467-019-10780-2
- Primary Citation of Related Structures:  
6O1O - PubMed Abstract: 
Type III-A CRISPR-Cas systems are prokaryotic RNA-guided adaptive immune systems that use a protein-RNA complex, Csm, for transcription-dependent immunity against foreign DNA. Csm can cleave RNA and single-stranded DNA (ssDNA), but whether it targets one or both nucleic acids during transcription elongation is unknown ...